Table 4. The baseline parameters predicting ΔHt SDS and ΔGV after 3 years of GH treatment in patients with idiopathic or organic GHD.
| Parameters | Idiopathic GHD (n = 131) | Organic GHD (n = 32) | ||||||
|---|---|---|---|---|---|---|---|---|
| Parameter | β a | P value | R 2b | Parameter | β a | P value | R 2b | |
| ΔHt SDS | IGF-1 SDS | −0.209 | < 0.001 | 0.157 | HT SDS | −0.415 | 0.045 | 0.679 |
| BA | −0.058 | 0.002 | 0.094 | |||||
| ΔGV | MPH SDS | 0.964 | 0.016 | 0.066 | HT SDS | −2.963 | 0.022 | 0.241 |
GHD = growth hormone deficiency, Ht SDS = height standard deviation score, GH = growth hormone, BA = bone age, IGF-1 SDS = insulin like growth factor-1 standard deviation score, GV = growth velocity, MPH = mid-parental height.
aParameter estimate; bPartial variability.